Education
About Us
Working with TipRanks
Follow Us
Intellia Therapeutics (DE:38I)
FRANKFURT:38I
Intellia Therapeutics (38I) Ownership Overview
1.81% Insiders
16.82%
Mutual Funds
34.21% Other Institutional Investors
28.89% ETFs
18.27% Public Companies and
Individual Investors
The ownership structure of Intellia Therapeutics (DE:38I) stock is a mix of institutional, retail, and individual investors. Approximately 79.92% of the company’s stock is owned by Institutional Investors, 1.81% is owned by Insiders, and 18.27% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Oct 03, 2025 | xxxxxxxxxxxxx | $32518 | |
Oct 03, 2025 | xxxxxxxxxxxxx | $539 | |
Aug 22, 2025 | xxxxxxxxxxxxx | $1003000 | |
Jul 25, 2025 | xxxxxxxxxxxxx | $104617 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Sep 30, 2025 | xxxxxxxxxxxxx | $3471235 | |
Sep 30, 2025 | xxxxxxxxxxxxx | $10486344 | |
Sep 30, 2025 | xxxxxxxxxxxxx | $47435059 | |
Sep 30, 2025 | xxxxxxxxxxxxx | $205844204 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 12,931,784 | Institution | 11.16% | 108,717,508 | |
| 11,919,178 | Institution | 10.29% | 100,204,529 | |
| 9,352,311 | Institution | 8.07% | 78,624,879 | |
| 8,604,908 | Institution | 7.43% | 72,341,462 | |
| 4,673,254 | Institution | 4.03% | 39,288,046 | |
| 2,977,386 | Institution | 2.57% | 25,030,884 | |
| 2,746,674 | Institution | 2.37% | 23,091,288 | |
| 1,489,621 | Institution | 1.29% | 12,523,244 | |
| 1,221,546 | Institution | 1.05% | 10,269,537 | |
| 1,173,954 | Institution | 1.01% | 9,869,431 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 8,604,908 | Institution | 7.43% | 72,341,462 | |
| 1,489,621 | Institution | 1.29% | 12,523,244 | |
| 1,221,546 | Institution | 1.05% | 10,269,537 | |
| 1,173,954 | Institution | 1.01% | 9,869,431 | |
| 1,056,519 | Institution | 0.91% | 8,882,155 | |
| 713,455 | Institution | 0.62% | 5,998,016 | |
| 558,615 | Institution | 0.48% | 4,696,276 | |
| 520,930 | Institution | 0.45% | 4,379,459 | |
| 512,085 | Institution | 0.44% | 4,305,099 | |
| 483,574 | Institution | 0.42% | 4,065,407 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Intellia Therapeutics (DE:38I)?
According to the latest TipRanks data, approximately 34.21% of the company's stock is held by institutional investors, 1.81% is held by insiders, and 18.27% is held by retail investors.
What percentage of Intellia Therapeutics (DE:38I) stock is held by institutional investors?
According to the latest TipRanks data, approximately 34.21% of Intellia Therapeutics (DE:38I) stock is held by institutional investors.
What percentage of Intellia Therapeutics (DE:38I) stock is held by retail investors?
According to the latest TipRanks data, approximately 18.27% of Intellia Therapeutics (DE:38I) stock is held by retail investors.
Who owns the most shares of Intellia Therapeutics (DE:38I)?
ARK owns the most shares of Intellia Therapeutics (DE:38I).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.